Combination treatment for hepatitis C is not being givenBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7265.899/a (Published 07 October 2000) Cite this as: BMJ 2000;321:899
View Full Text
- G R Foster (email@example.com), consultant hepatologist,
- R Chapman, consultant gastroenterologist
- Liver Centre, Imperial College School of Medicine at St Mary's, St Mary's Hospital, London W2 1PG
- Department of Gastroenterology, John Radcliffe Infirmary, Oxford OX3 9DU On behalf of C Change
EDITOR—Current estimates suggest that up to 0.7% (400 000 individuals) of the population of the United Kingdom are infected with the hepatitis C virus.1 In some (roughly 30%) of these people the virus causes a progressive hepatitis that leads to cirrhosis and cancer.2 European guidelines recommend that patients with progressive hepatitis C are treated with interferon and ribavirin.3 This cures 40%4 and leads to an improvement in …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.